A biopterin synthesis defect caused hyperphenylalaninemia in an infant. Tetrahydrobiopterin (BH4) therapy normalized phenylalanine, indicating no central nervous system impact.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Observation:
Findings:
Implications: